Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen Beats on Top and Bottom Lines, but Shares Drop
Bizjournals.com
Wednesday, April 20, 2011 - 7:00pm
tags:
Amgen, earnings
Dynavax gets $6M for start of human tests of lupus treatment
Bizjournals.com
Wednesday, April 20, 2011 - 6:55pm
tags:
lupus, GSK, Dynavax, DV1179
Turnaround at Johnson & Johnson? Let's Do Some Math.
Motley Fool
Wednesday, April 20, 2011 - 6:54pm
tags:
JNJ
CROs scramble as Big Pharma lines up strategic partnerships
Fierce Biotech
Wednesday, April 20, 2011 - 12:20pm
tags:
CROs, Big Pharma, R&D, Covance, PPD, Parexel, Charles River Laboratories, ICON, Kendle, Quintiles
J&J defends executive pay to institutional investors
Fierce Pharma
Wednesday, April 20, 2011 - 12:07pm
tags:
JNJ, executive pay
Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug
Yahoo/AP
Wednesday, April 20, 2011 - 12:06pm
tags:
Gilead Sciences, RSV, MicroDose Therapeutx, MDT-637
Elan turns 1Q profit as Tysabri sales rise
Yahoo/AP
Wednesday, April 20, 2011 - 12:04pm
tags:
Elan, earnings
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wednesday, April 20, 2011 - 12:04pm
tags:
FDA, Genentech, vasculitis, Rituxan
Lilly Will Pay Investors For Patience
Investopedia
Wednesday, April 20, 2011 - 12:02pm
tags:
invesors, Eli Lilly
Mylan now selling generic version of Novartis' herpes drug Famvir
Yahoo/AP
Wednesday, April 20, 2011 - 12:01pm
tags:
Mylan, generics, Famvir, Novartis, herpes zoster
Sangamo Biosciences's Game Changing Technology
Seeking Alpha
Wednesday, April 20, 2011 - 9:57am
tags:
Sangamo BioSciences, ZFP technology
U.S. Backs Roche Cervical Cancer Test
WSJ Online
Wednesday, April 20, 2011 - 9:56am
tags:
Roche, cervical cancer
Is BioSante Giving Away the Store?
Motley Fool
Wednesday, April 20, 2011 - 9:55am
tags:
BioSante, Aduro BioTech, pancreatic cancer, prostate cancer
Dendreon's Price Run May Be in Anticipation of Stronger Earnings
Seeking Alpha
Wednesday, April 20, 2011 - 9:54am
tags:
Dendreon, Provenge, prostate cancer
SciClone buys U.S.-backed Chinese drug company
Bizjournals.com
Wednesday, April 20, 2011 - 9:52am
tags:
China, SciClone, M&A, NovaMed
FDA Heightens Painkiller Oversight
WSJ Online
Wednesday, April 20, 2011 - 9:51am
tags:
painkillers, opiods, FDA
Abbott 1Q profit falls 14 percent on charges
Yahoo/AP
Wednesday, April 20, 2011 - 9:50am
tags:
earnings, Abbott Laboratories
What Drug Did Doctors Prescribe Most Last Year?
WSJ Online
Tuesday, April 19, 2011 - 10:18pm
tags:
physicians, prescription data, Vicodin, generics
Covidien, Zalicus drugs hit by new federal 'opioid strategy'
Bizjournals.com
Tuesday, April 19, 2011 - 10:16pm
tags:
Covidien, Zalicus, opiods, Exalgo, JNJ
The Fall of Lipitor
Minyanville
Tuesday, April 19, 2011 - 10:15pm
tags:
Pfizer, Lipitor, generics, patents

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.